C12N 2760/18822
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/18822 (New viral proteins or individual genes, new structural or functional aspects of) appears on 36 US grants and 52 published applications in this corpus.
Search patents in C12N- Granted patents
- 36
- Published applications
- 52
- Assignees
- 29
- Inventors
- 96
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 3 |
| 2003 | 2 | 6 |
| 2004 | 3 | 2 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 4 | 5 |
| 2009 | 0 | 2 |
| 2010 | 3 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 0 | 1 |
| 2017 | 3 | 1 |
| 2018 | 0 | 3 |
| 2019 | 1 | 2 |
| 2020 | 0 | 2 |
| 2021 | 2 | 3 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 3 | 3 |
| 2025 | 2 | 5 |
By publication year. Applications have been published since 2001.
Recent patents
- Fusosome compositions and uses thereof5 Aug 2025US 12,378,578 B2Flagship Pioneering Innovations V, Inc.
- Paramyxovirus vector18 Mar 2025US 12,252,700 B2ID Pharma Co., Ltd.
- Storage method and banking system of NT cell17 Sep 2024US 12,091,679 B2Cha Biotech Co., Ltd.
- Temperature-based transient delivery of nucleic acids and proteins to cells and tissues13 Aug 2024US 12,060,568 B2Elixirgen Therapeutics, Inc.
- Gene and cell therapy using cell fusion technology4 Jun 2024US 11,998,617 B2Curamys Inc.
- Fusosome compositions and uses thereof4 Dec 2025US 2025/0369018 A1Flagship Pioneering Innovations V, Inc.
- Rna virus-derived chimeric envelope protein and rna virus vector having same6 Nov 2025US 2025/0340899 A1Tokiwa-Bio Inc.
- Temperature-sensitive negative-strand rna virus or virus vector and rna genome thereof30 Oct 2025US 2025/0333760 A1Repli-Tech Co., Ltd.
- Retroviral vectors5 Jun 2025US 2025/0177574 A1IP2Ipo Innovations Limited
- Temperature-based transient delivery of nucleic acids and proteins to cells and tissues23 Jan 2025US 2025/0027111 A1Elixirgen Therapeutics, Inc.
Most cited
By later US patents
- Indicator cell line for detecting RNA viruses and method therefor30US 5,591,579 AWashington University · 1997
- Antigen presenting system and methods for activation of T-cells27US 6,255,073 B1The Scripps Research Institute · 2001
- Synthetic antigen presenting matrix16US 6,461,867 B1The Scripps Research Institute · 2002
- Method for producing a synthetic antigen presenting transformed Drosophila cell15US 6,362,001 B1The Scripps Research Institute · 2002
- Antigen presenting system and methods for activation of T-cells14US 6,225,042 B1The Scripps Research Institute · 2001